Cenobamate (syrup) for 2 to < 18 year olds + Cenobamate (tablet) for 12 to < 18 year olds for epilepsies, partial

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 May 2026: Trial registered, NCT07594158
  2. 10 Jun 2026: Trial started, NCT07594158

The trials

NCT07594158: A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds

State
Under way
Phase
Phase 3
People
20 planned
Started
10 Jun 2026
Primary completion
30 Mar 2028
Arms
2 to < 18 year olds
Results
None posted
  1. 18 May 2026: Trial registered
  2. 10 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.